SF
Seamus Fernandez Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
32
Avg Return
Past Year
Past Year
51%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
91.2%
Neutral
8.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $11 |
166%
upside
| 1 | +1.7% |
0
%
| 18 Nov ‘25 18 days ago |
|
|
|
Neutral
Downgraded
| – | – | 5 | +92% |
0
%
| 18 Nov ‘25 18 days ago |
|
|
|
Buy
Maintained
| $77 |
141%
upside
| 3 | +88% |
0
%
| 10 Nov ‘25 26 days ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | – |
–
| 23 Oct ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $948 |
6%
downside
| 6 | +6.8% |
0
%
| 16 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $25 |
76%
upside
| 2 | +77% |
0
%
| 15 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $14 |
45%
upside
| 1 | +63% |
0
%
| 14 Aug ‘25 3 months ago |
|
|
|
Buy
Maintained
| $90 |
160%
upside
| 1 | +112% |
0
%
| 7 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $120 |
15%
upside
| 1 | +18% |
0
%
| 6 Aug ‘25 4 months ago |
|
|
|
Buy
Reiterated
| $116 |
51%
upside
| 3 | +22% |
0
%
| 2 Jul ‘25 5 months ago |
|
|
|
Buy
Reiterated
| – | – | 3 | +43% |
0
%
| 3 Apr ‘25 8 months ago |
|
|
|
Buy
Reiterated
| – | – | 1 | +92% |
0
%
| 25 Mar ‘25 8 months ago |
|
|
|
Buy
Reiterated
| $160 |
244%
upside
| 2 | -23% |
0
%
| 12 Mar ‘25 8 months ago |
|
|
|
Buy
Initiated
| $56 | – | 1 | +137% |
0
%
| 25 Feb ‘25 9 months ago |
|
|
|
Buy
Reiterated
| – | – | 1 | +303% |
0
%
| 24 Feb ‘25 9 months ago |
|
|
|
Buy
Maintained
| $122 |
22%
upside
| 1 | -0.97% |
0
%
| 17 Jan ‘25 10 months ago |
|